NCT01500070 - PREVENT: Promus BTK | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Peripheral Arterial Disease

Interventions

DEVICE

Everolimus-Eluting Stent (PROMUS ELEMENT)

PROMUS ELEMENT Everolimus-Eluting Stent System (Boston Scientific) or PROMUS ELEMENT PLUS Everolimus-Eluting Stent System (Boston Scientific).

Trial Locations (8)

Auckland City Hospital, Auckland

Imelda Hospital, Bonheiden

RZ Heilig Hart Tienen, Tienen

AZ Sint-Blasius, Dendermonde

OLV Aalst, Aalst

St. Fransiskus Hospital, Münster

Herzzentrum Bad-Krözingen, Bad-Krözingen

Herzzentrum Leipzig, Leipzig

All Listed Sponsors

lead

Flanders Medical Research Program

NETWORK